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Comparative evaluation of in vivo
biocompatibility and biodegradability of
regenerated silk scaffolds reinforced
with/without natural silk fibers
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Ali Moshiri1, Mohammad-Mehdi Naderi1, Hamed Heidari-Vala1,
Javad Ashrafi Helan2, Sayeh Khanjani1, Armin Springer3,
Mohammad-Mehdi Akhondi1 and Somaieh Kazemnejad1
Abstract
Nowadays, exceptional advantages of silk fibroin over synthetic and natural polymers have impelled the scientists to
application of this biomaterial for tissue engineering purposes. Recently, we showed that embedding natural degummed
silk fibers in regenerated Bombyx mori silk-based scaffold significantly increases the mechanical stiffness, while the porosity
of the scaffolds remains the same. In the present study, we evaluated degradation rate, biocompatibility and regenerative
properties of the regenerated 2% and 4% wt silk-based composite scaffolds with or without embedded natural
degummed silk fibers within 90 days in both athymic nude and wild-type C57BL/6 mice through subcutaneous implant-
ation. In all scaffolds, a suitable interconnected porous structure for cell penetration was seen under scanning electron
microscopy. Compressive tests revealed a functional relationship between fiber reinforcement and compressive modulus.
In addition, the fiber/fibroin composite scaffolds support cell attachment and proliferation. On days 30 to 90 after
subcutaneous implantation, the retrieved tissues were examined via gross morphology, histopathology, immunofluores-
cence staining and reverse transcription-polymerase chain reaction as shown in Figure 1. Results showed that embedding
the silk fibers within the matrix enhances the biodegradability of the matrix resulting in replacement of the composite
scaffolds with the fresh connective tissue. Fortification of the composites with degummed fibers not only regulates the
degradation profile but also increases the mechanical performance of the scaffolds. This report also confirmed that
pore size and structure play an important role in the degradation rate. In conclusion, the findings of the present study
narrate key role of additional surface area in improving in vitro and in vivo biological properties of the scaffolds and suggest
the potential ability of these fabricated composite scaffolds for connective tissue regeneration.
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Introduction
Healing and regeneration of large connective tissue
defects are major challenge in trauma surgery.1,2 The
current procedures using autografts and allografts are
associated with significant limitations and complica-
tions such as the need for multiple surgeries, additional
surgical time/cost, donor-site morbidity and limited
supply in overly large defects. Tissue engineering and
regenerative medicine (TERM) approaches that deliver
scaffolds, cells and growth factors directly into
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affected defects hold great potential for achieving opti-
mal healing in these difficult cases, while eliminating the
drawbacks related to conventional treatments.3,4
Scaffolds as main components of fabricated constructs
should be able to substitute the missing part of the
targeted tissue and boost its regeneration. In addition,
these structures should have suitable biocompatibility,
biodegradability, appropriate mechanical properties
and desired bioactivity.5 Nowadays, the scientists have
been fascinated by silk biomaterials due to exceptional
advantages of silk fibroin over synthetic and natural
polymers. Low immunogenicity, cell affinity, modifiable
degradation rates and impressive mechanical properties
make silk as a promising candidate for TERM goals.6–8
Nevertheless, variety of silk scaffolds can be developed
from aqueous to solvent formulations of the natural
fiber for utilizing in different targets.9–11
Actually appropriate degradation rate is an essential
requirement for biocompatibility of an engineered
cell-scaffold construct. Suitable degradation rate con-
sistent with the new tissue ingrowths results in the
mechanical and structural integrity with surrounding
host tissue.12,13 Although natural unprocessed silk as
an FDA-approved biomaterial has been introduced as
non-biodegradable material, according to the literature,
silk fibroin is classified as enzymatically degradable
polymer.14 In vitro and in vivo studies revealed that
silk fibroin degradation behavior is highly influenced
by structural characterization, original preparation
methods, solvent, porosity and morphology of scaffold
and host immune system elements during degrad-
ation.15,16 Therefore, modification in physical form
and post-treatment of silk biomaterials may allow
tuning rate of degradation.
Recently, to construct an appropriate scaffold for
osteochondral tissue engineering, a novel Bombyx
mori silk-based composite scaffold was fabricated by
embedding the natural degummed silk fibers within a
matrix of regenerated fibroin for tissue engineering
purpose. These highly porous scaffolds hold more
compressive modulus compared to regenerated fibroin
without natural silk fibers with the same porosity.17
However, in vivo biocompatibility and biodegradabil-
ity of this modified composite scaffold remained to be
assessed. In the present study, we examined in vivo
degradation rate and biocompatibility of the 2%
and 4% wt regenerated silk-based composite scaffolds
with or without embedded natural degummed silk
fibers in animal model. Because ‘‘subcutaneous
implantation’’ is assumed to be a suitable model for
evaluation of biodegradation,16–19 the scaffolds were
implanted subcutaneously and examined within 90
days in both athymic nude and wild-type C57BL/6
mice via histopathology, immunofluorescence staining
and reverse transcription-polymerase chain reaction
(RT-PCR).
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Figure 1. Illustrative summary of the main methods and findings.
RS: regenerated silk; RSF: regenerated fibroin/ silk fiber composite scaffolds; H&E: Hematoxylin and eosin; COX-1: Cyclooxygenase.
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As a main goal, we evaluated the role of silk fibers
and regenerated fibroin concentration in the biodegrad-
ation behavior and regenerative capacity of the com-
posite scaffolds composed of regenerated fibroin
matrix/natural silk fibers.
Materials and methods
Ethics
The investigators who undertook the measurements
and analyses of the results were unaware of the experi-
mental design and grouping details. All operative pro-
cedures were performed by one surgeon. All animals
received human care in compliance with the Guide
for Care and use of Laboratory Animals published by
the National Institutes of Health (NIH publication no.
85-23, revised 1985). The study was approved by bio-
ethic committee of Avicenna Research Institute.
Preparation of silk fibroin scaffolds
Silk fibroin was extracted from Bombyx mori silkworm
cocoons (Provided by Iranian silkworm Research
Center; Guilan, Iran) according to the procedures
described in our previous studies.17,20 Briefly, three
cocoons were boiled for 1 h in 750mL of 0.02M
Na2CO3 (Merck, Darmstadt, Germany) solution,
rinsed with deionized water and dried overnight. The
dried and degummed fibers containing water-insoluble
fibroin were dissolved in 9.3M LiBr (Merck,
Darmstadt, Germany) solution (10wt% fibers) for 5 h
at 55C and dialyzed with cellulose dialysis tubes
(12KDa cut-off value) (Sigma Aldrich, Taufkirchen,
Germany) against ultra-pure water for 36 h. The fibroin
solution was freeze-dried to allow storage of the
extracted fibroin at room temperature (RT).
For preparation of the regenerated silk (RS) scaf-
folds, the lyophilized fibroin was dissolved in ultra-
pure water to a final concentration of 2 and 4% wt,
respectively. The scaffolds were fabricated in disc-
shaped matrices (3 4mm) by pouring 140 mL of the
fibroin solution per well into 96-well tissue culture poly-
styrene plates (TTP, Trasadingen, Switzerland). Then,
the scaffolds were freeze-dried to generate porous
matrix, which were then treated with 99.98% methanol
(Merck, Darmstadt, Germany) for 1 h to regenerate
b-sheet domains. Finally, to eliminate the methanol,
the scaffolds were rinsed and freeze-dried, again.
Regenerated fibroin/silk fiber composite scaffolds
(RSF) consisting of natural degummed silk fibers and
regenerated fibroin were fabricated in disc shape as
fully described in our previous work.17 Degummed
silk fibers were filled into 96-well tissue culture polystyr-
ene plates. At fibers top, 140mL of the 2 % wt fibroin
solution was slowly poured to reach a mass ratio of silk
fiber per dry fibroin as 10:4. In a similar manner with
RS scaffolds, the RSF scaffolds were frozen, freeze-
dried and treated with methanol (99.98%) in order to
restore the b-sheet structure of the fibroin matrix.
Characterization of the fabricated scaffolds
Extracted fibroin protein was analyzed by Fourier
transform infrared spectroscopy (FT-IR) pre-and
post-methanol treatment using 55FTIR EQUINOX
spectrophotometer (BrukerOptik GmbH, Ettlingen,
Germany). Freeze-dried fibroin was mixed with KBr
and precipitated. The pellets were analyzed in the
range of 4000 to 500 cm1 with a resolution of
4 cm1. To determine the conformation of both the
methanol-treated and non-treated SF scaffolds, they
were manually crushed to a fine powder by agate
mortar. X-ray scans were performed by a SIEMENS
D5000 diffractometer (Siemens, Munich, Germany) at
40 kV and 40mA. All scans were extended from 5 to
70 in 2y using Cu-Ka radiation.
After samples were gold coated using a sputter
coater, the morphology of the fibers was characterized
using a scanning electron microscope (SEM, Model
XL30; Philips Electron Optics, Eindhoven, the
Netherlands). Diameter of the fibers was measured
from the provided SEM images using image analysis
software.
Moreover, mechanical properties of the scaffolds
(n¼ 6) were measured using an Instron 5566 testing
machine (InstronWolpert GmbH, Pfungstadt,
Germany) equipped with a 100 N load cell at ambient
temperature. The crosshead speed was set at 1mm
min1 for static uniaxial loading compression experi-
ment. Cylinder-shaped samples measuring between 6.5
and 8mm in diameter and ranging 9–13mm in height
were used, according to the modified ASTM method
F451-95.21–23 The samples were prepared using razor
blades in dry condition and the compressive stress
and strain were (elastic modulus) determined as previ-
ously described.17
In vitro cytocompatibility of scaffolds
To assess in vitro cytocompatibility of the prepared
scaffolds, the morphology of human bone marrow-
derived mesenchymal stem cells (hBMSCs) grown on
the scaffolds was studied 21 days post cell seeding by
SEM. Briefly, the hBMSCs were isolated from bone
marrow aspirates (5–10mL) using a combination of
density gradient centrifugation and plastic adherence
as described in our previous studies.24 Before cell
seeding, the disc-shaped scaffolds were sterilized by
Gama-irradiation (30–35 kGy) and then immersed in
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Dulbecco’s modified Eagle’s medium (DMEM)-low
glucose overnight. The bone marrow-derived mesen-
chymal stem cells (BMSCs) grown in cell culture
flasks were trypsinized, counted and plated at a density
of 1.2 105 cells/cm2 onto the surface of prepared scaf-
folds. Cellular scaffolds were incubated at 37C for 1 h
to allow BMSCs to diffuse into and adhere to the scaf-
fold before the addition of 1mL of medium to each
well. The seeded cells on the scaffolds were cultured
in DMEM-low glucose supplemented with 15% fetal
bovine serum and 2mM L-glutamine in a humid
atmosphere of 5% CO2 and 95% air at 37
C. At 14
and 21 days after cell seeding, the cell–scaffold con-
structs were rinsed twice with phosphate-buffered
saline (PBS) and fixed in 2.5% glutaraldehyde for 2 h.
The scaffolds were further rinsed with PBS and fixed in
1% Osmium Tetroxide for 1.5 h. After washing with
PBS, samples were dehydrated with increasing concen-
trations of ethanol (50%, 70%, 90% and 100%) for
20min each. Thereafter, the cell–scaffold constructs
were air-dried overnight. After drying, the scaffolds
were mounted on aluminum stubs and coated with
gold–palladium (AuPd). Finally, surfaces of the various
specimens were analyzed by Philips XL 30/ESEM
(Philips, Eindhoven, The Netherlands).
In vivo implantation of silk-based scaffolds
To obtain the information regarding biodegradability,
biocompatibility and regenerative properties of the silk-
based scaffolds (RS 2 and 4% wt and RSF 2% wt),
in vivo subcutaneous implantation test was accom-
plished in three time points in both male athymic
nude and C57BL/6 mice (weighing 20–25 g). The ani-
mals were anesthetized by intramuscular administra-
tion of Ketamine HCL (50mg/kg) and Xylazine HCL
(5mg/kg). Under aseptic condition, six longitudinal
skin incisions (5mm length) were made on the
dorsum back of three athymic nude mice and the
disk-shaped (3 4mm) RS 2% wt (n¼ 2) and 4% wt
(n¼ 2) and RSF 2% wt (n¼ 2) scaffolds were implanted
subcutaneously in each animal (totally six scaffolds in
each). Based on the in vivo results obtained from
implantation of the scaffolds in nude mice, the RS
(n¼ 9) and RSF (n¼ 9) 2% wt scaffolds were selected
and implanted in another nine C57BL/6 mice so that in
each animal two types of scaffolds (RS 2%: n¼ 1; RSF
2% n¼ 1) were implanted subcutaneously on the
dorsum back. Skin incisions were approximated by
metal clips. Postoperative analgesia and antibiotic
were provided by intramuscular administration of
Tramadol (10mg/kg) twice a day for three days and
Gentamicin (10mg/kg) daily for five days, respectively.
After induction of short-time anesthesia, the wound
clips were removed seven days later. Then, the animals
were euthanized to retrieve the scaffolds for analysis 30,
60 and 90 days after implantation. Nude mice were
considered as external control for C57BL/6 mice
while in each animal, each scaffold was considered as
internal control for the other scaffold/s.
Sample collection
In each time point, totally 36 scaffolds in 12 mice were
evaluated. Half of the scaffolds were dissected from
nude mice, while another half was dissected from
C57BL/6 mice. For gross morphology, all the scaffolds
were evaluated. Each scaffold was sectioned and
divided into two parts. The first part was used for his-
topathologic and fluorescent microscopic evaluations,
while another part was used for RT-PCR analyses.
Gross and histopathologic examinations
For gross pathology, the hyperemia, development and
quality of the capsule, biodegradability and other gross
characteristics were qualitatively evaluated and
reported by two expert comparative healing patholo-
gists. Immediately after euthanasia, the remained
parts of the implanted scaffolds together with the cover-
ing newly regenerated tissues were harvested, collected
and fixed in buffered formalin (10%) for at least 24 h.
Then the samples were dehydrated in a graded series of
ethanol, cleared in xylene, embedded in paraffin wax,
sectioned at 4–5 mm, and stained with either the
Hematoxylin and eosin (H & E) and Alcian blue and
nuclear fast red (AB-NFR).The stained slides were
evaluated under a light microscope (Olympus BX51,
Tokyo, Japan) connected to a digital camera
(Olympus DP71) by two expert pathologists. In each
group of scaffolds, five histopathologic fields (100)
were used for semi-quantitative analyses. The percent-
age of filled pores with the newly regenerated tissue per
total pores, number of the remained pores inside the
scaffold, total cellularity, fibroblast, fibrocyte, neutro-
phil, lymphocyte, macrophage, total vascularity and
small-, medium- and large sized vessels were counted
at triplicate. The counting was performed by software
(Photoshop CC, ADOBE Corp., CA and Image J,
NIH, CA).
For immunohistochemical staining of
Cyclooxygenase-2 (COX-2), non-specific binding sites
on the sections were blocked with 10% goat serum in
PBS and incubated with COX-2 polyclonal antibody
(1:200) (Thermo scientific Inc. Waltham, MA) and
secondary FITC-conjugated goat anti-rabbit Ig
(1:200) (Abcam, Cambridge, London). All the sections
were counterstained with DAPI (4, 6-diamidino-2-
phenylindole; 1:1000) (Sigma Aldrich Co. LLC.USA)
for nuclear staining. The tissue samples were visualized
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and photomicrographed using an epifluorescence
microscope (Olympus BX51, Tokyo, Japan) connected
to a digital camera (Olympus DP71).
RT-PCR
RT-PCR was performed to assess expression of a set of
inflammation-related genes including interleukin-6 (IL-
6), COX-2 and tumor necrosis factor-a (TNF-a) in the
retrieved samples. Briefly, total RNA was extracted
from tissue samples using RNeasy Mini Kit (Qiagen,
Valencia, USA). Reverse transcription was performed
using 2 mg purified RNA and SuperScriptTM II Reverse
Transcriptase kit (Gibco, New York, USA) in a ther-
mocycler (Eppendorf, Germany). Then, 1 mL of cDNA
was admixed with 12.5 mL reaction master mix
(Amplicon, Copenhagen, Denmark) and 1 mL of each
primer (Table 1). After initial denaturation at 95C for
10 s, PCR amplification was continued at 95C for 5 s
and 60C for 30 s for 40 cycles. Finally, dissociation
stage was performed at 95C for 15 s, 60C for 1min
and 95C for 15 s. The amplified DNA fragments were
electrophoresed on 2% agarose gel and visualized by
ultra-violet transilluminator (Uvitec, Cambridge, UK).
Expression of each gene was corresponded to TATAA-
box-binding protein (TBP) as an internal control.
RAW264.7 (Mouse leukemic monocyte macrophage
cell line) (Eton Bioscience. Inc. San Diego, CA)
was used as a positive control. For semi-quantitative
determination, specific band density was normalized
to that of the corresponding using AlphaEase
software (Genetic Technologies, Inc., Fitzroy Vic
3065 Australia).
Statistical analyses
For multiple comparisons, One Way ANOVA with its
subsequent post hoc Tukey tests was used, while for
two comparisons the measured values were compared
using Independent sample t-test. The results were
expressed as mean standard deviation. A value of
P< 0.05 was considered statistically significant.
Results
Physical and mechanical characteristics of the
fabricated scaffolds
XRD and FT-IR analyses were carried out to charac-
terize extracted fibroin before and after methanol treat-
ment. Before methanol treatment, XRD results showed
two strong peaks around 2y¼ 14 and 16.5 representing
silk I structure for extracted fibroin. After methanol
treatment, the peaks shifted to 2y¼ 20 and 21, respect-
ively, indicating a conformation change from silk I to
silk II with its crystalline b-sheet structure (Figure 2(a)).
Protein characteristic peaks were found at different dis-
tinguishable vibration peak ranges relating to amide
groups. Proteins showed characteristic vibration
bands at 1650–1630 cm1 for amide I (C¼O stretch-
ing), 1540–1520 cm1 for amide II (secondary NAH
bending), and 1270–1230 cm1 for amide III (CAN
and NAH functionalities) in their FT-IR spectra. In
Figure 2(b), peaks of fibroin before methanol treatment
positioned at 1638, 1531 and 1242 cm1 represent
amides I, II and III, respectively. Moreover, the peak
at 658 cm1 was a validation for amide V. FT-IR
revealed a silk I structure of the extracted fibroin.
After methanol treatment, characteristic peaks at
1633, 1514 and 1235 cm1 representing amides I, II
and III, respectively, were found. The change of wave
number of the vibration bands indicated the reorgan-
ization of hydrogen bonds due to the methanol treat-
ment, characteristic for silk II formation.
During the mechanical assessment, none of the sam-
ples fractured. Compressive moduli (elastic modulus) of
RS scaffolds rose with increasing fibroin concentration,
starting at 0.16MPa for RS 2wt%, 1.20MPa for
RS 4% wt and reaching 13.97MPa for RSF 2% wt,
showing a high significant difference (P¼ 0.001) among
Table 1. Sequences of the primers used for analysis of inflammation-related genes in sample tissues.
Name of gene Primer sequence Product size (bp) NCBI accession number
TNF-a F 50-CCCAAAGGGATGAGAAGTTC-30 245 NM_013693.3
R 50- GGAGTAGACAAGGTACAACC-30
COX-2 F 50-CAGCACTTCACCCATCAGT-30 181 NM_011198.3
R 50-GATACACCTCTCCACCAATG-30
IL-6 F 50-CACGGCCTTCCCTACTTCAC-30 186 NM_031168.1
R 50- GCAAGTGCATCATCGTTGT-30
TBP F 50- AAGGGAGAATCATGGACCAGAAC-30 149 NM_013684.3
R 50-GGTGTTCTGAATAGGCTGTGGAG-30
TNF-a: Tumor necrosis factor-a; COX-2: cyclooxygenase-2; IL-6: interleukin-6; TBP: TATAA-box binding protein.
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each other. Thus, by adding fibers as reinforcing factor
to the fibroin matrix, compressive moduli improved sig-
nificantly more than 10 folds (Figure 2(c)).
Based on the SEM images, the RS showed a well
porous structure as both the longitudinal, transverse
sections of the scaffold were highly porous, and the
pores were formed both on the surface and in the inter-
nal parts of the scaffold. Indeed, the pores were ran-
domly but homogenously distributed all over the
scaffold. By decrease in the concentration of RS
matrix, the pore size significantly increased so that the
RS 2% wt scaffolds had significantly larger pores
(300mm with median porosity of 90%) than those of
the 4% wt ones (100mm with mean porosity of 87%).
RS with more than 4% wt concentration showed less
pore size (<70 mm). The morphological assessment of
RSF 2% wt scaffolds clearly showed that the fibers
were embedded and randomly distributed all over the
RS matrix. The mean pore size and porosity of RSF
2% were 200 mm and 88%, respectively. Image analyses
of the SEM micrographs of the cell-seeded scaffolds
exhibited that the cells penetrated and adhered on the
surface of all the three scaffolds. Moreover, the cells
expanded and distributed all over the scaffold surfaces
during 21 days post cell seeding. As shown in Figure 3,
the cell–cell interaction, proliferation and distribution
over surfaces in RS 2% and RSF 2% wt is more sig-
nificant than that of RS 4%. However, cells penetration
is more typical in RSF 2% and RS 4% wt compared to
RS 2% wt.
Gross pathology and histopathological findings
In nude mice. As shown in Figures 4 and 6, the RSF 2%
wt scaffold architecture was not preserved and
gradually degraded post-subcutaneous implantation.
More connective tissue covered the RSF 2% wt scaf-
folds when compared to those of the RS 2% and 4% wt
ones. In addition, the hyperemia was well developed
and distributed all over the covering connective tis-
sue of the RSF 2% wt scaffold, while in those of the
RS 4% wt ones, the hyperemia was almost limited to
the center of the connective tissue. RSF 2% wt scaf-
fold triggered development of the fibrous connective
tissue subcutaneously so that the developing tissue con-
sisting of vascular structures and fibrous-like texture
was well extended subcutaneously even outside the
scaffold. This characteristic was not seen in other
scaffolds.
Based on the qualitative and quantitative data
obtained from H & E and Alcian Blue stained sections
(Figures 4 and 6, Table 2), the RS 2% wt scaffolds were
partially degraded during 90 days post-subcutaneous
implantation in nude mice. On day 90, a few capsular
tissues surrounded the scaffolds and a newly regener-
ated tissue evenly developed in situ. Unlike RS 2% wt,
in the 4% wt one, a fibrous tissue well encapsulated the
scaffold, one month post implantation. In this time, the
scaffold was filled with the newly regenerated connect-
ive tissue consisting of fibroblast and collagenous
tissue. Indeed, some sections of the RS 4% wt scaffold
were infiltrated by the fibroblasts so that the cells pro-
liferated and produced matrix and the newly regener-
ated tissue expanded and compressed the free pores.
Interestingly, large blood vessels were formed inside
the scaffold (RS 4% wt), at 90 days post implantation
leading to an inflammatory reaction. In the case of RSF
2% wt scaffold, a well-organized connective tissue cov-
ered the scaffold 30 days post subcutaneous implant-
ation so that it is well integrated with the newly
developed connective tissue. The architecture of the
pores and silk sheet was almost completely degraded
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and replaced with the new connective tissue 30 days
post implantation, while the natural silk fibers were
present inside the scaffold at that time. Although the
silk fibers of the RSF 2% wt scaffold remained in the
nude mice even after 90 days, their transverse diameter
slightly decreased as measured by software (ADOBE
Photoshop CS-6. CA).
Ninety days post subcutaneous implantation, in the
RSF 2% wt scaffolds, significantly higher number of
pores were filled with the newly regenerated tissue
(P¼ 0.001) and lower number of pores remained in
the scaffolds compared to those of the RS 4% wt
ones (P¼ 0.001). At this stage, the RSF 2% wt scaf-
folds had significantly higher fibroblast and fibrocyte
compared to those observed in the RS 4% wt
scaffolds (P¼ 0.001 for all) (Table 2). After 60 days
post subcutaneous implantation of the RS 4% wt scaf-
fold in nude mice, the architecture of the scaffold was
completely preserved and was not degraded. The scaf-
fold was surrounded by the capsular-like tissue
and fibroblasts were laid between the matrices but the
number of macrophages was higher than the fibro-
blasts. Thirty days later, the newly regenerated
blood vessels were well developed inside the scaffold;
however, at this stage, numerous lymphocytes and
macrophages were infiltrated the scaffold. (Figure 4,
Table 2).
In wild-type C57BL/6 mice. The assessment of biocompati-
bility and biodegradability of RS 2% wt and RSF 2%
wt scaffolds was followed in wild-type C57BL/6 mice
without immune suppression.
After subcutaneous implantation of the RS 2% wt
and RSF 2% wt scaffolds in the C57BL/6 mice, differ-
ent patterns of biocompatibility, biodegradability and
regenerative capacity were seen in those of the RS 2%
wt scaffolds when compared to their in vivo character-
istics in nude mice (Figures 5 and 7). Unlike to those
observed in nude mice, the RS 2% wt scaffolds were
covered with a loose low thickness capsule in normal
mice at day 30 post implantation. In addition, a
number of inflammatory cells entered the scaffold and
attached to its pores at that stage. After staining with
Alcian blue-nuclear fast red, a better morphology of the
cluster-like cells was seen and the structure of scaffold
with the new matrix was better defined from each other.
No evidence of connective tissue regeneration was evi-
dent 30 days post subcutaneous implantation of the
scaffold. At 60 days post implantation, the internal
architecture of the RS 2% wt scaffold was almost com-
pletely free of any cellular structures similar to that
observed for the scaffold architecture before implant-
ation. However, at this stage, the thickness of the cap-
sule slightly increased and some blood vessels were
evident in the covering capsule. In addition, a new
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matrix originating from the capsule started to fill the
scaffold at periphery. At 90 days post implantation, the
capsule thickness increased and some parts integrated
within the newly regenerated tissue inside the scaffold.
Through the course of the experiment, between days 30
to 90, the architecture of the scaffold was completely
preserved but at long term, only a few evidences of
regeneration were seen suggesting the scaffold has low
biocompatibility and almost no biodegradability with
minimum regenerative capacity in C57BL/6 mice.
Unlike the RS 2% wt scaffolds, the RSF 2% wt scaf-
folds showed a similar pattern with RSF 2% wt scaf-
folds implanted in nude mice so that, 30 days post
implantation, the RS matrix of the scaffold was
almost completely degraded and replaced by the new
connective tissue. Only their diameter slightly decreased
by passing time. The covering capsule was well inte-
grated with the connective tissue that regenerated
inside the scaffold. At long-term follow-up, only few
amounts of capsule were detected and the capsule
mostly incorporated with the scaffold. In a comparative
evaluation, the RSF 2% wt scaffold exhibited higher
percentage of filled pores and significantly lower
number of the remained pores compared to the RS
2% wt scaffolds at different time points (P¼ 0.001 for
all). In addition, the RSF2% wt scaffolds had signifi-
cantly higher number of fibroblast, fibrocyte and total
vessels and lower number of macrophages compared to
the RS 2% wt scaffolds (P¼ 0.001 for all) (Table 2).
The protein and mRNA expression of inflammatory
factors in implanted scaffolds
Immunofluorescent staining of inflammatory factor
‘‘COX-2’’ showed a downward manner of this marker
expression during three months post implantation of
RS 2% wt RSF 2% wt RS 4% wt
Figure 4. Histopathological appearance of different scaffolds, 90 days post subcutaneous implantation in athymic nude mice. The RS
2% wt scaffold has been partially degraded by the host (A, D, G) and a considerable part of it has been filled with the newly
regenerated tissue (G; N.R.T). In addition, the architecture of the scaffold has been partially preserved and some remnants of the RS
scaffold (G; arrow). A connective tissue like capsule (C.) has covered the RSF 2% wt scaffold (B, F). The regenerated matrix of the RSF
2% wt scaffold has been almost degraded by the host and replaced by the newly regenerated tissue (H; N.R.T.) but the natural fibers
are present in the scaffold. These fibers have been sectioned both longitudinally (H; thin arrow) and transversely (H; thick arrow). The
architecture of the RS 4% wt scaffold has not been altered even after 90 days (C, F, I). The pores (free spaces between the regenerated
matrixes (I, arrows) are still present. Some of the pores have been filled with the newly regenerated tissue (N.R.T.) but some others
are still free of any regeneration. Scale bar: A to C: 125 mm, D to F: 50 mm, G to I: 25mm. Color staining: H&E.
RS: regenerated silk; RSF: regenerated fibroin/ silk fiber composite scaffolds.
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Table 2. Histopathologic characteristics of various scaffolds after one to three month of subcutaneous implantation in normal and nude mice.
Animal type
Athymic nude C57BL/6 mice
Scaffold type
RS 4% wt RS 2% wt RSF 2% wt RS 2% wt RSF 2% wt
Month 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3
Filled pores/total
pores (%)
ND 58.4 10.71 59.6 8.59 ND ND 85.8 5.76 ND 87 6.78 83 5.78 29.4 10.06 32 10.29 48.8 4.6 71.4 5.63 81.2 4.81 84.8 6.14
Remained pores (n) 75.4 24.31 73.8 14.49 21.8 7.04 3 2.73 3.2 1.64 36.2 6.79 34.4 6.65 32 5.24 6.6 2.5 2.4 2.07 2.4 2.88
Total cellularity (n) 332.2 37.95 808.6 112.79 405.2 38.52 504.2 70.86 406.4 26.04 675 58.39 848.6 96.11 277.6 38.13 571.6 71.75 427.4 64.1 390.4 18.84
Fibroblast (n) 64 10.34 70.4 8.44 52.4 12.34 389.8 25.85 282.8 31.31 151.4 8.44 233.2 28.92 83.4 12.44 361 58.11 261 34.09 188.4 27.59
Fibrocyte (n) 21.8 8.04 25.6 6.38 21.2 3.19 46 7.31 80.4 10.01 32.2 6.37 93.2 20.93 25.6 6.69 28.4 4.15 80.8 11.9 98.6 11.76
Lymphocyte (n) 13.2 5.93 52 12.84 7 2.73 18.8 5.81 10.6 5.36 40.4 12.23 15 5.24 15.8 6.01 29 4.3 12 4.41 6.6 5.41
Neutrophil (n) 0.6 0.54 9.2 6.22 0.4 0.54 0.4 0.89 0 4.4 4.27 1.2 1.3 0 1.6 1.51 0.6 0.89 0
Macrophage (n) 257 38.96 723.6 87.25 269.6 45.45 60.2 13.91 41 14.37 410.4 44.59 500.4 29.21 119.4 18.94 184 13.47 108.2 14.34 95 12.76
Small vessels (n) 2 1.58 14.6 2.88 12.6 3.97 4.4 2.07 4.2 0.83 5 1.22 3.6 2.5 3 2.12 9.8 3.42 3.8 1.09 3 2.44
Medium vessels (n) 0 3 1 1.48 0 1.2 0.83 0 0 0 0 0 0
Large vessels (n) 0 2.8 1.2 0.83 0.2 0.44 1.2 0.83 0 0 0 0 0 0
n¼ histopathologic field¼ 5, Counting magnification¼100. Adobe Photoshop CC and Image J were used for cell and other tissue structure counting. The results are expressed as Mean Standard
deviation. One way ANOVA with its subsequent post hoc Tukey test was used to statistically test the results and P< 0.05 was considered statistically significant.
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the RSF 2% wt in the C57BL/6 mice (Figure 8(a)).
Moreover, the mRNA expression of IL-6, COX-2 and
TNF-a was assessed 30 and 90 days post implantation.
As shown in Figure 8(b), although the implanted RSF
2% wt scaffolds in the C57BL/6 mice expressed IL-6
and COX-2 mRNA 30 days after transplantation, the
mRNA expression of these markers down regulated 90
days post implantation; however, there were no
significant differences between the TNF-a mRNA
expression of the tissues retrieved at 30 and 90 days
post-implantation.
Discussion
Developing an appropriate scaffold, which can provide
mechanical, physical and biological support and guide
d30
RSF 2%
 wt
RS 2%
 wt
d60 d90
Figure 5. Histological appearance of RSF and RS 2% wt post subcutaneous implantation in C57BL/6 mice. After subcutaneous
implantation of the RSF 2% wt in C57BL/6 mice (A to F), the RS matrix was almost degraded and replaced by the newly regenerated
tissue (N.R.T.). The connective tissue like capsule has covered the scaffold but also it has integrated with the new matrix within the
scaffold. The natural fibers are still present even 90 days post implantation so that the longitudinally (D; arrow head) and transversely
(E, F: arrow head) sectioned fibers could be seen at all-time points. Few remnants of the regenerated silk matrix could be seen (E, F:
arrow). After implantation of the RS 2% wt scaffold, a new capsular tissue has covered the scaffold at 30 days post implantation while
time dependently its thickness has increased so that on day 90, it has invaded inside the scaffold. The newly regenerated tissue has
been originated from the covering capsule and is indicated by red line (G, H, I). On day 30, only few inflammatory cells have infiltrated
the scaffold (J). These cells have been apoptozed or dead due to their lifespan (K) so that the internal parts of the scaffold are free of
any regenerative evidence (K). On day 90, some regenerative evidences (L; between arrows head) could be seen inside the scaffold but
still most parts of the scaffold are free (L). No evidence of degradation could be seen so that the regenerated matrix (J, K, L; arrows) is
almost present at all-time points. Scale bar: A to C and G to I: 125 mm; D to F; J to L 50mm. Color staining: H&E.
RS: regenerated silk; RSF: regenerated fibroin/ silk fiber composite scaffolds.
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cell growth to the new tissue, is essential aspect in
osteochondral tissue engineering.25 Fiber-reinforced
scaffolds have been in the focus of the attention due
to the presence of suitable mechanical properties
along with proper porosity.26 We showed that embed-
ding natural silk fibers in the RS matrix would be able
to increase the young modulus of the 2wt% RS scaf-
folds up to ten folds (13.97MPa), while the porosity of
the scaffolds are almost the same. This improvement
is due to transferring the mechanical loads to the
fibers which originally have superior mechanical prop-
erties than the RS matrix.17 In addition to appropriate
physical and mechanical properties, in preliminary
part of this study, we showed that this RS scaffold
mediates suitable matrix for attachment, homing and
proliferation of BMSCs recommending it as a good
candidate for reconstruction of osteochondral tissues.
Subsequently, we have evaluated the in vivo behavior of
subcutaneously implanted RS and RSF scaffolds to
figure out the effect of embedded fibers in the composite
construct on biodegradation and tissue regeneration
during three months in mice. Subcutaneous model
was considered for the in vivo study based on the ease
of the implantation surgery and the need to evaluate
biodegradation and biocompatibility of scaffolds in
vascular tissues.16–19 We demonstrated that the RSF
2% wt scaffolds are biocompatible, partially biodegrad-
able and have superior regenerative properties com-
pared to those of the RS 2 and 4% wt ones.
Biodegradability of an tissue engineered construct is
an important factor for development of a newly regen-
erated tissue in the shortest possible time.16,27,28 Low
biodegradability of the natural silk fibers has been
endorsed by showing long-term degradation of at
least 6 to 24 months by the host immune system
(Table 3). In vitro and in vivo investigations regarding
the RS fibroin have shown that aqueous-derived scaf-
folds degrade quicker with less immune system reaction
Figure 6. Alcian Blue staining of subcutaneously implanted scaffolds, 90 days post implantation in nude mice. (A, D and G)
regenerated Silk (RS) 2% wt group; (B, E and H): RSF 2% wt; (C, F, I) RS 4% wt. Note the newly regenerated matrix has been stained
blue while the cellular structures and the scaffold has been stained red. The RS 2% wt scaffold has not been degraded by the host, but
the newly regenerated tissue has well filled the free spaces of the scaffold and the free pores. In contrast to the RS 2%, the RSF 2%
scaffold has been almost completely degraded but the natural fibers are still present (H; thick arrow). The newly regenerated matrix
(H; arrow head) has well filled the free spaces of the scaffold and covered the fibers. In the RS 4% group, less matrix has regenerated
inside the scaffold, the architecture (I, arrow) of the scaffold is still preserved and more free spaces in the scaffold could be seen. Scale
bar: A to C: 50mm; D to F: 25mm; G to I: 12.5 mm. Stained with AB/NFRS.
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Figure 7. Alcian Blue staining of subcutaneously implanted scaffolds in C57BL/6 mice. In the RSF 2% scaffolds, a thick capsule (c) has
covered the scaffold at 30 days post implantation (A; Arrows). By passing time from day 30 to 90, the thickness of the capsule has been
decreased so that at 90 days (C), the capsule has completely merged with the scaffold. In the RSF group, most of the regenerated Silk
matrix has been degraded and replaced by the newly regenerated tissue (N.R.T.), large and matured blood vessels have filled the
internal parts of the scaffold (H; arrow), the natural fibers have not been degraded but time dependently the density of the newly
regenerated tissue (N.R.T.) has been increased. In the RS 2% wt scaffold, a loose capsule (c) has covered the scaffold but its thickness
has been increased, time dependently. The architecture of the scaffold has been completely preserved by the host. At mid to long-term
follow-up, few matrix (Q, arrow head) has infiltrated the free pores of the scaffold (Q, arrow). Scale bar: A to C, J to L; 125 mm; D to F,
M to O; 50 mm; G to I and P to R; 25mm. (Stained with AB/NFR).
RS: regenerated silk; RSF: regenerated fibroin/ silk fiber composite scaffolds.
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in comparison with organic solvent-derived scaf-
folds.16,29–31 However, based on the knowledge of the
authors, there is no systematic study reported the deg-
radation behavior of degummed silk fibers in vivo. In
the present study, the in vivo degradation of degummed
silk fibers in combination with aqueous-derived RS
fibroin was investigated.
We showed that it is possible to improve the biocom-
patibility, biodegradability and regenerative capacity of
silk-based scaffolds by two-step optimization including
decrease in the concentration of the RS matrix and
assembling the matrix with the natural degummed silk
fibers.
Based on the findings of the present study, although
natural silk fibers had low in vivo biodegradability in
both nude and C57BL/6 mice, the RS matrix was com-
pletely degraded and replaced by the newly developed
connective tissue through embedding the natural fibers
within the matrix, suggesting the natural silk fibers may
have a role in increasing the biodegradability of the RS
matrix. It seems that the natural silk fibers probably
boost the degradation of the regenerated matrix
due to a slight rise in initial foreign body reaction.
These data may emphasize the ability of these fibers
in escalating the specific surface area, which results in
increasing the number of immigrated cells within the
RS matrix. The superior cellular infiltration response
observed in the RSF 2% wt scaffolds compared to
those of the RS 2 and 4 % wt ones, confirmed the
above theory. A robust evidence for this assumption
was lower degradation rate of the RS 4% with smaller
pore size and subsequently less cell infiltration com-
pared to those of the RS 2% and RSF 2% ones with
larger pore size and higher cell infiltration level.
Another important characterization of a construct is
its biocompatibility, endorsing the ability of a construct
to be tolerated by the host immune response.5 Based on
our results, the degradation behavior of RSF 2% wt
scaffolds in nude mice is superior compared to that of
the RS 2 and 4% wt ones. Moreover, the higher areas
of newly developed interconnected well-differentiated
matrix was observed in RSF 2% wt constructs suggest-
ing that embedding the natural fibers within the regen-
erated matrix has a considerable value in increasing the
biocompatibility of the construct. Unlike RSF 2% wt,
high infiltration of immune cells long term post
COX-2 DAPI COX-2/DAPI
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NC
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Figure 8. Immunofluorescent staining and RT-PCR. (a) The expression of COX-2 protein was evaluated in the RSF 2% wt scaffold, 30
and 90 days post subcutaneous implantation in mice. Negative controls (NC) included rabbit IgG substitution of primary antibody.
Samples have been incubated with DAPI (1:1000) for nuclear staining. Scale bar: 500mm (b) RT-PCR; Gene expression of the
inflammatory markers (TNF-a, IL-6 and COX-2) in the RSF 2% wt scaffolds, 60 and 90 days post subcutaneous implantation in C57BL/
6 mice. TBP, RAW264.7 (mouse leukemic monocyte macrophage cell line; RC) and D.D.W. have been used as internal, positive and
negative controls, correspondingly.
TNF-a: Tumor necrosis factor-a; COX-2: cyclooxygenase-2; IL-6: interleukin-6; TBP: TATAA-box binding protein.
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Table 3. Degradation of B. Mori Silk, in vivo and in vitro studies.
Silk-based material
Pore
Size (mm)
In vitro study In vivo study
ReferenceDegradation degree Conditions Duration
Degradation
degree In vivo model Duration
8% wt-aqueous
derived
850 30% reduce in surface
area
PBS 37C 56 days – – – (Park et al.29)
8% wt- organic solvent
HFIP (hexafluoro-2-
isopropanol)
850 9% reduce in surface
area
PBS 37C 56 days – – – (Park et al.29)
1% wt fibroinþ 3% wt
chitosan
100–150 18% mass loss PBS 37C 60 days – – – (Zhu et al.23)
Degummed silkfiber
scaffolds
Mesh  3% mass loss PBS &nbsp;37C 42 days – – – (Horan et al.30)
Degummed silkfiber
scaffolds
Mesh 50% mass loss PBS 37Cþ protease
XIV (1mg/ml)
42 days – – – (Horan et al.30)
Degummed silkfiber
scaffolds
Mesh 25% mass loss PBS 37Cþ protease
XXIII (1mg/ml)
10 weeks – – – (Srihanam and
Simchuer31)
6% wt aqueous derived 850–1000 – – – 100% Lewis rat/
subcutaneously
24 weeks (Wang et al.8)
10% wt aqueous
derived
850–1000 – – – 67% Lewis rat/
subcutaneously
24 weeks (Wang et al.8)
6% wt organic solvent
HFIP (hexafluoro-2-
isopropanol)
850–1000 0% Lewis rat/
subcutaneously
1 year (Wang et al.8)
PBS: phosphate-buffered saline.
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implantation in nude mice narrates low biocompatibil-
ity of the RS 4 % wt scaffold.
Regenerative capacity is another necessary concept
for the identification of in vivo efficacy of tissue-
engineered scaffolds. There are several factors that
determine the regenerative capability of a scaffold
including scaffold porosity, pore size and morphology,
biodegradation profile and biocompatibility.32,33 Based
on the results observed in the nude mice, the RS 2% wt
and RSF 2% wt scaffolds exhibited superior regenera-
tive properties than those of the RS 4% wt ones. Unlike
those of the 4% wt scaffolds, the architecture of the RS
2% wt ones was partially replaced by the new tissue.
The tissue almost completely expanded throughout the
scaffold and no islands of regenerated tissue were simi-
lar to those observed in the 4% ones so that the regen-
erated tissue in the RS 2% wt scaffold showed more
homogeneity. Embedding the natural non-degradable
silk fibers within the regenerated matrix increased the
regenerative properties of the scaffold so that more
homogenous newly regenerated tissue with a denser
structure had formed in the RSF 2% wt scaffolds com-
pared to those of the RS 2 and 4 % wt ones.
Undesirable regenerative properties of RS 4% wt
may be attributed to the low biodegradability of this
construct inhibiting the connection between regener-
ated matrices to establish.
With retrieving the primary data regarding differ-
ences between different silk-based scaffolds in nude
mice, we cancelled the study of RS 4% wt scaffold
and investigated behavior of the RS 2% wt and RSF
2% wt scaffolds in C57BL/6 mice subsequently. These
following investigations were settled to more assess-
ment of biodegradation, biocompatibility and regenera-
tive properties of RSF2% wt scaffold in a wild type
instead of athymic nude animal. Based on our results,
although implantation of the RS 2% wt scaffold in
nude mice suggested the biocompatibility of the scaf-
fold, subcutaneous implantation of the RS 2% wt scaf-
fold in the C57BL/6 mice resulted in a different
judgment. In fact, after subcutaneous implantation of
the RS 2% scaffold in C57BL/6 mice, few inflammatory
cells infiltrated in the internal parts of the scaffold at 30
days post implantation, while at 60 days almost no cell
was seen inside the scaffold suggesting the cells were
dead due to their life span. In a similar manner with
nude mice, the regenerative capability of the scaffolds in
the C57BL/6 mice judged by degradation of the RS
matrix by the host and the matrix replacement by the
more homogenous new tissue was significantly higher
in RSF 2% wt compared to RS 2% wt scaffolds. While
after three months, low tissue ingrowths developed in
the RS 2% wt scaffolds, this characteristic was
observed in the RSF 2% only after 30 days of implant-
ation. Following these results, the biocompatibility of
RSF 2% wt scaffolds was more confirmed by assess-
ment of inflammatory factors like COX-2, IL-6 and
TNF-a. Initial immune response judged by expression
of COX-2 and IL-6 could be attributed to better cellu-
lar access due to the presence of fibers and angiogenesis
which accelerates degradation.16 However, this early
inflammation subsided over the time. Although COX-
2 and IL-6 factors were time-dependently down-regu-
lated, TNF-a showed no significant changes. Based on
the available reports showing an important physio-
logical role of TNF-a in regulating skeletal muscle
regeneration,34 it seems that the expression of the
TNF-a in the RSF 2% wt scaffolds, even after 90
days, probably had improving effects on the
regeneration.
Based on these data, although biodegradation time
of silk fibers are much more than other natural poly-
mers like collagen (4–12 weeks),35,36 embedding the nat-
ural degummed silk fibers within the RS matrix is a
novel technology that shortens biodegradation time of
silk-based scaffolds. The newly regenerated tissue
replaced the RS matrix, was a non-aligned tissue
and this was due to the porous structure of the scaffold,
which we have shown in our in vitro results.17,20
Such a construct with the numerated and well discussed
characteristics may be a suitable option in bone and
or cartilage tissue engineering purposes because both
these structures have bulky architecture and the
matrix is not aligned in these tissues.8 However, more
studies are needed to elucidate its beneficial effects on
the healing and regeneration of injured bone or
cartilage.
Conclusion
This study investigated in vivo biodegradability and
biocompatibility of the regenerated silk scaffolds,
which reinforced with natural degummed silk fibers.
The results showed that the presence of degummed
silk fibers in the composite scaffolds, significantly
enhances the mechanical compressive properties to
more than 10 folds compared to those without natural
fiber. Moreover, the biocompatibility, biodegradability
and regenerative properties were observed in the rein-
forced scaffolds were more typical when compared to
controls. These outcomes demonstrated that embed-
ding the silk fibers within the matrix enhances the bio-
degradability of the matrix through giving a rise in
specific surface area of scaffolds and resulting in
almost complete replacement of the scaffolds with the
fresh connective tissue. The findings of the present
study indicate the key role of the embedded fibers in
improving the mechanical and biological properties of
the silk-based scaffolds and suggest the potential ability
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of the presented scaffold for connective tissue regener-
ation especially osteochondral defects.
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